Northern Trust’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.37M Sell
19,975
-344
-2% -$58.8K ﹤0.01% 2674
2025
Q4
$3.43M Buy
20,319
+1,897
+10% +$308K ﹤0.01% 2692
2025
Q3
$2.66M Buy
18,422
+269
+1% +$36.7K ﹤0.01% 2874
2025
Q2
$2.3M Sell
18,153
-4,091
-18% -$502K ﹤0.01% 2909
2025
Q1
$2.85M Sell
22,244
-3,135
-12% -$425K ﹤0.01% 2735
2024
Q4
$3.36M Buy
25,379
+967
+4% +$136K ﹤0.01% 2745
2024
Q3
$3.55M Sell
24,412
-473
-2% -$68.4K ﹤0.01% 2680
2024
Q2
$3.42M Sell
24,885
-2,465
-9% -$329K ﹤0.01% 2610
2024
Q1
$3.75M Sell
27,350
-1,146
-4% -$157K ﹤0.01% 2644
2023
Q4
$3.87M Buy
28,496
+1,210
+4% +$148K ﹤0.01% 2654
2023
Q3
$3.34M Sell
27,286
-1,526
-5% -$194K ﹤0.01% 2669
2023
Q2
$3.66M Sell
28,812
-1,202
-4% -$156K ﹤0.01% 2674
2023
Q1
$3.88M Buy
30,014
+212
+0.7% +$27.8K ﹤0.01% 2608
2022
Q4
$3.91M Sell
29,802
-3,498
-11% -$452K ﹤0.01% 2631
2022
Q3
$3.9M Sell
33,300
-1,910
-5% -$237K ﹤0.01% 2640
2022
Q2
$4.14M Sell
35,210
-3,426
-9% -$407K ﹤0.01% 2625
2022
Q1
$5.04M Sell
38,636
-4,992
-11% -$650K ﹤0.01% 2583
2021
Q4
$6.66M Buy
43,628
+6,385
+17% +$989K ﹤0.01% 2521
2021
Q3
$6.02M Sell
37,243
-3,558
-9% -$599K ﹤0.01% 2615
2021
Q2
$6.68M Sell
40,801
-1,881
-4% -$290K ﹤0.01% 2650
2021
Q1
$6.43M Sell
42,682
-3,795
-8% -$603K ﹤0.01% 2586
2020
Q4
$7.04M Sell
46,477
-3,686
-7% -$527K ﹤0.01% 2474
2020
Q3
$6.79M Buy
50,163
+862
+2% +$117K ﹤0.01% 2343
2020
Q2
$6.74M Sell
49,301
-4,464
-8% -$569K ﹤0.01% 2343
2020
Q1
$5.79M Sell
53,765
-5,278
-9% -$608K ﹤0.01% 2208
2019
Q4
$7.12M Sell
59,043
-2,958
-5% -$330K ﹤0.01% 2384
2019
Q3
$6.17M Sell
62,001
-2,165
-3% -$227K ﹤0.01% 2429
2019
Q2
$7M Sell
64,166
-7,706
-11% -$820K ﹤0.01% 2365
2019
Q1
$8.04M Sell
71,872
-3,982
-5% -$437K ﹤0.01% 2296
2018
Q4
$7.31M Sell
75,854
-6,382
-8% -$677K ﹤0.01% 2269
2018
Q3
$10M Sell
82,236
-7,552
-8% -$889K ﹤0.01% 2253
2018
Q2
$9.86M Buy
89,788
+1,098
+1% +$117K ﹤0.01% 2277
2018
Q1
$9.47M Sell
88,690
-11,208
-11% -$1.24M ﹤0.01% 2199
2017
Q4
$10.7M Sell
99,898
-18,734
-16% -$2M ﹤0.01% 2140
2017
Q3
$13.2M Buy
118,632
+1,170
+1% +$125K ﹤0.01% 2015
2017
Q2
$12.1M Sell
117,462
-3,063
-3% -$302K ﹤0.01% 2039
2017
Q1
$11.8M Sell
120,525
-1,329
-1% -$127K ﹤0.01% 2011
2016
Q4
$10.8M Sell
121,854
-15,864
-12% -$1.44M ﹤0.01% 2068
2016
Q3
$13.3M Buy
137,718
+4,434
+3% +$422K ﹤0.01% 1877
2016
Q2
$11.4M Sell
133,284
-7,761
-6% -$696K ﹤0.01% 1936
2016
Q1
$12.3M Sell
141,045
-10,503
-7% -$939K ﹤0.01% 1822
2015
Q4
$17.1M Sell
151,548
-846
-0.6% -$91.8K 0.01% 1615
2015
Q3
$15.4M Sell
152,394
-9,411
-6% -$1.13M 0.01% 1683
2015
Q2
$19.9M Buy
161,805
+1,110
+0.7% +$133K 0.01% 1590
2015
Q1
$18.4M Buy
160,695
+45
+0% +$4.96K 0.01% 1645
2014
Q4
$16.2M Buy
160,650
+6,411
+4% +$623K ﹤0.01% 1698
2014
Q3
$14.1M Sell
154,239
-5,646
-4% -$495K ﹤0.01% 1786
2014
Q2
$13.7M Sell
159,885
-4,560
-3% -$359K ﹤0.01% 1812
2014
Q1
$13M Buy
164,445
+10,950
+7% +$912K ﹤0.01% 1920
2013
Q4
$11.6M Sell
153,495
-1,449
-0.9% -$103K ﹤0.01% 1970
2013
Q3
$10.8M Buy
154,944
+5,991
+4% +$392K ﹤0.01% 1975
2013
Q2
$8.63M Buy
+148,953
New +$8.61M ﹤0.01% 2024

Other funds holding IBB

Northern Trust's IBB Position: Q1 2026 in Review

Northern Trust reduced its iShares Biotechnology ETF (IBB) stake by 1.7% in Q1 2026, selling an estimated $58.8K and leaving 19,975 shares worth $3.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2674.

Northern Trust first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.9M in Q2 2015. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Northern Trust held 19,975 shares of iShares Biotechnology ETF worth $3.37M as of Q1 2026.
  • Northern Trust sold 344 iShares Biotechnology ETF shares in Q1 2026, an estimated $58.8K.
  • iShares Biotechnology ETF made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2674 holding.
  • Northern Trust first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • Northern Trust's iShares Biotechnology ETF position peaked at $19.9M in Q2 2015.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.